Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1890
https://www.valueinhealthjournal.com/article/S1098-3015(17)32224-6/fulltext
Title :
Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32224-6&doi=10.1016/j.jval.2017.08.1890
First page :
A713
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1718